Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00003017
First received: November 1, 1999
Last updated: June 20, 2013
Last verified: July 2004